Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Lenalidomide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 35 Lymphoma, Follicular 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 7 Lymphoma, Non-Hodgkin 6 Recurrence 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms, Plasma Cell 3 Smoldering Multiple Myeloma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 HTLV-I Infections 1 GATA2 Deficiency 1 Anemia, Refractory, with Excess of Blasts 1 Anemia 1

Interventions

X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trametinib 1 etoposide phosphate 1 erdafitinib 1 ensartinib 1 dabrafenib 1 Sirolimus 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡